First quarter revenues for the IBO Lab Equipment/Consumables Index jumped 12.4% to $799 million. Operating profits improved 25.6% to $232 million, and operating margin climbed 310 basis points to 29.0% of sales. Fisher Scientific’s merger with Thermo Electron had a significant impact on the revenue and operating growth for the Index (see IBO 5/15/06). Fourteen […]

Tecan elected Heinrich Fischer, former CEO of the Saurer Group, and Jürg Meier, former head of the Novartis Venture Fund, to its board, replacing Heino von Prondzynski, who resigned, and Timothy Anderson. The April election defeated candidates and motions put forward by BB Medtech, the company’s largest shareholder. NanoString Technologies is developing with Applied Precision […]

In 2006, the German Research Foundation (DFG) had €1.41 billion ($1.76 billion) in income, according to the foundation’s annual report. Of this income, 58.2% came from the national government, 41.0% from local government and 0.4% from foundations and private companies. In the first round of the Excellence Initiative, 18 graduate schools, 17 clusters of excellence […]

In the June 30 issue, IBO examined the acquisition of molecular diagnostic providers by companies traditionally associated with research instrumentation and products. QIAGEN NV is one such company. QIAGEN currently offers 34 CE-marked IVD assays, six CE-marked IVD sample preparation products, nine China State Food and Drug Administration– approved IVD assays and one FDA 510K-approved […]

St. Louis, MS and Richmond, CA 7/10/07—Sigma-Aldrich has licensed Sangamo BioSciences’ zinc finder DNA-binding proteins (ZFPs) for development of research reagents for the regulation of gene expression in living cells. Sigma-Aldrich also acquired rights to sublicense the technology for research applications. Sigma-Aldrich will initially pay Sangamo $13.75 million in the form of an upfront licensing […]

INFICON’s Emergency Response & Security reported 2006 sales decreased 15.7% to $18.3 million to make up 9% of the total company’s revenues. Torion Technologies named Douglas W. Later, PhD, president and CEO last year. He was previously senior market development manager and director of corporate marketing for Dionex. Ion Signature developed a customized version of […]

This month truly exemplified the unpredictable nature of the stock market. Just as investors seemed to embrace a renewed faith in steady interest rates and unrelenting mergers and acquisitions, questions surrounding the housing market and federal interest rates resurfaced. The Dow Industrial Average and S&P 500 began June with new highs of 13,676.32 and 1,539.18, […]

Recent acquisitions have highlighted the evolving relationship of instrument companies and the molecular diagnostics market. Last month, QIAGEN acquired Digene, the largest provider of human papillomavirus (HPV) diagnostics tests, for $1.6 billion (see IBO 6/15/07). Earlier this year, Agilent acquired Stratagene for $246.2 million (see IBO 4/15/07). These developments follow acquisitions last year by Luminex […]

Madison, WI 6/19/07—Roche has agreed to acquire microarray company NimbleGen Systems for $272.5 million. In 2006, NimbleGen posted revenues of $13.5 million and total losses of $8.3 million (see IBO 3/31/07). NimbleGen will join Roche’s Applied Science business, part of Roche Diagnostics, whose other research products include PCR instruments and reagents, and the recently acquired […]